Dr. Pezalla is Founder and CEO of Enlightenment Bioconsult, LLC, a strategic payer consultancy advising biopharmaceutical firms on access, technology assessment, and drug evaluation in the US market. His clients include established pharmaceutical firms and emerging companies with innovative therapies.

Dr. Pezalla served for nine years as VP for Pharmaceutical Policy and Strategy for Aetna, and four years as VP of Clinical Services for RxSolutions. In these roles he developed programs for drug and device evaluation, creation of clinical policy and formulary inclusion. Dr. Pezalla also served as the leading executive for Aetna on public policy issues related to drug approval, drug pricing and regulation. He is a member of the MIT Center for Biomedical Innovation NEWDIGS project and was a member of the inaugural class of Scholars-in-Residence at the Duke-Margolis Center for Health Policy.